Acrivon Therapeutics, Inc. (ACRV)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

11

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Nov-24 10:00 PM View:	14-Nov-24 Payment of Exercise ($4.85K)	Devroe Eric Chief Operating Officer		Acrivon Therapeutics, Inc. - ACRV	(1%) 68.48K to 67.87K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 4:31 PM View:	14-Nov-24 Payment of Exercise ($1.46K)	Miller Mary Chief Legal Officer		Acrivon Therapeutics, Inc. - ACRV	0% 38.13K to 37.94K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 10:00 PM View:	14-Nov-24 Payment of Exercise ($3.18K)	Gamelin Erick Chief Development Officer		Acrivon Therapeutics, Inc. - ACRV	(2%) 17.36K to 16.96K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 4:32 PM View:	14-Nov-24 Payment of Exercise ($0.78K)	Peterson Katharine Chief Accounting Officer		Acrivon Therapeutics, Inc. - ACRV	(2%) 4.63K to 4.54K	0	0	--	--	Show Txns Hide Txns